HAART of similar benefit for HIV-infected injection drug users
Monday, August 4, 2008 - 08:21
in Health & Medicine
Contrary to the belief that HIV-infected injection drug users (IDUs) receive less benefit from highly active antiretroviral therapy (HAART), new research finds little difference in the survival rate between IDUs and non-IDUs after 4-5 years of receiving HAART...
Read the whole article on Science Centric
More from Science Centric
Related
- Highly active antiretroviral therapy of similar benefit for HIV-infected injection drug usersSun, 3 Aug 2008, 14:35:21 EDT
- Study suggests HIV-infected patients should start HAART soonerMon, 27 Oct 2008, 10:15:30 EDT
- Efavirenz-based initial therapies associated with better outcomes in HIV-infected adultsTue, 14 Oct 2008, 14:29:00 EDT
- Maternal HIV-1 treatment protects against transmission to newbornsFri, 16 Oct 2009, 11:16:06 EDT
- Tijuana injection drug users on collision course for HIV and TBWed, 15 Apr 2009, 18:56:36 EDT